Sign in

You're signed outSign in or to get full access.

Kevin Sayer

Kevin Sayer

Chief Executive Officer at DEXCOMDEXCOM
CEO
Executive
Board

About Kevin Sayer

Kevin R. Sayer, 67, is Chairperson, President and Chief Executive Officer of DexCom, Inc. (DXCM). He has served on the Board since November 2007, has been President since 2011, CEO since January 2015, and Chairperson since July 2018. He holds a B.A. and a Master’s Degree in Accounting and Information Systems from Brigham Young University and is a Certified Public Accountant (inactive) . Under his leadership, Dexcom reported 2024 revenue of $4.03B (+11% YoY), net income of $576.2M (+6% YoY), and operating cash flow of $989.5M (+32% YoY). Non-GAAP operating margin was 18.8% for 2024. Five-year absolute TSR to 12/31/24 was 42%, with 5-year TSR CAGR of 7% .

Past Roles

OrganizationRoleYearsStrategic impact
Dexcom (Medtronic MiniMed predecessor role)VP & GM, Medtronic MiniMed2001–2002Led post-acquisition integration/operations following Medtronic’s acquisition of MiniMed .
MiniMed, Inc.Chief Financial Officer1994–2001Scaled diabetes-device leader to acquisition by Medtronic .
Specialty Laboratories, Inc.EVP & Chief Financial Officer2004–2005Corporate finance leadership at clinical lab services company .
Biosensors International Group, Ltd.Chief Financial Officer2007–2010CFO at interventional cardiology/critical care medtech firm .
Independent consultantHealthcare/medtech consultant2002–2004; 2005–2007Advised medtech and healthcare companies .

External Roles

OrganizationRoleYearsNotes
No other current public company boards; Board committees: none .

Fixed Compensation

Metric (CEO)20242023
Base salary ($)1,157,254 1,092,822
Target annual cash bonus (%)140% (raised from 130% in 2023) 130%
Target annual cash bonus ($)1,620,156 n/a
Actual annual cash bonus ($)0 (no 2024 bonus paid) 1,988,948
All other compensation ($)135,432 143,535

Multi-year compensation mix (as reported):

Metric202220232024
Salary ($)953,424 1,092,822 1,157,254
Stock awards ($)13,212,746 12,486,939 14,536,111
Non-equity incentive plan comp ($)1,251,370 1,988,948 — (0)
All other compensation ($)18,112 143,535 135,432
Total ($)15,435,652 15,712,244 15,828,797

Performance Compensation

2024 equity grant design and outcomes:

AwardGrant dateShares (#)Grant-date fair value ($)Vesting termsKey terms/outcome
RSU (Annual)3/8/202451,692 6,640,675 Vests over 3 years in equal annual installments CEO equity split targeted 50% RSU / 50% PSU in 2024 .
PSU (Annual)3/8/2024Target 51,692; Threshold 10,339; Max 103,384 7,895,436 Performance-based (1-year corporate metric; 3-year relative TSR) 2024 corporate performance metric threshold not achieved; no vesting for 2024 PSUs .
Total 2024 equity103,384 (RSU+PSU targets) 14,536,111 Mix ensures long-term alignment and retention .

2024 annual cash bonus formula and metrics (resulted in zero payout):

ComponentWeightingThreshold/TargetActualPayout
Adjusted Revenue componentn/dThreshold: ≥$4.15B $4.03B (below threshold) 0% component (below threshold)
Non-GAAP Operating Margin componentn/dThreshold: ≥18.0% 18.8% (met threshold) Eligible, but overall bonus = 0%
CEO Strategic Initiatives20% of CEO target Pre-set milestones n/d0% overall bonus due to company performance decision

Additional PSU program terms:

  • 2022 PSUs: Earned and certified Jan 28, 2025; vesting subject to continued service through certification date .
  • PSU performance periods: 2022 (corp metric 2022; relative TSR through 12/31/2024), 2023 (corp metric 2023; relative TSR through 12/31/2025), 2024 (corp metric 2024; relative TSR through 12/31/2026) .

2024 vesting activity:

Metric2024
Stock awards vested (shares)130,442
Value realized on vesting ($)16,897,013
Options exercisedNone in 2024

Equity Ownership & Alignment

MetricValue
Total beneficial ownership (shares)233,938 (less than 1%) as of March 13, 2025 .
Shares outstanding (record date)392,107,501 (for % calc) .
CEO stock ownership guideline6x base salary; CEO in compliance as of Mar 13, 2025 .
CEO post-vesting holding requirementMust hold net shares for ≥12 months post-vesting (limited exceptions) .
Hedging/pledgingCompany prohibits hedging and pledging of Company securities .

Outstanding equity as of 12/31/2024:

TypeShares unvested/unearned (#)Value ($)Vesting/Notes
RSUs (aggregate)178,14413,854,258 (at $77.77) Annual RSUs vest over 3 years in equal annual installments .
PSUs (aggregate unearned)212,22816,504,972 (at $77.77) 2022 PSUs earned/certified 1/28/2025; 2023–2024 PSUs in-flight .

Insider selling pressure indicators:

  • Significant annual vesting ($16.9M realized in 2024) can create periodic liquidity needs for tax withholding and diversification, although CEO is subject to a 12-month post-vesting holding period and anti-hedging/pledging constraints .

Employment Terms

Severance & Change-in-Control (CIC) plan design (Amended & Restated, adopted May 18, 2023):

ScenarioBase salary multipleBonus multipleHealth benefitsEquity acceleration
Qualifying termination (no CIC) – CEO24 months (lump sum) 1x prorated target (lump sum) Up to 24 months COBRA None
Qualifying termination within CIC period – CEO (double trigger)36 months (lump sum) 3x target (lump sum) Up to 36 months COBRA 100% acceleration; PSUs vest per award terms

Illustrative potential payments (assuming 12/31/2024 termination):

ScenarioCash severance ($)Non-equity incentive pay ($)PSU accel. ($)RSU accel. ($)Benefits ($)Total ($)
Qualifying Termination (No CIC)2,330,000 1,620,156 35,791 3,985,947
Qualifying Termination + CIC (Double Trigger)3,495,000 4,860,467 10,831,183 8,526,781 53,687 27,767,118

Other protections and policies:

  • Nasdaq-compliant clawback policy (adopted Aug 2023); recovery of incentive-based compensation upon certain restatements .
  • No single-trigger acceleration; no excise tax gross-ups; no option repricing without shareholder approval .

Board Governance

AttributeDetail
RolesCombined Chairperson and CEO (Kevin R. Sayer); Lead Independent Director: Mark G. Foletta .
IndependenceAll directors independent except the CEO .
CommitteesFour standing committees (Audit; Compensation; Nominating & Governance; Technology); Sayer serves on none .
2024 Board meetingsSix meetings; average attendance ~94%; each director ≥75% attendance except one (Karen Dahut) .
Committee attendance 2024Audit 96%; Compensation 93%; Nominating & Governance 88%; Technology 88% .
Nominee biography snapshotAge 67; Board since 2007; no committee assignments; no other public boards .

Dual-role implications:

  • Board maintains a Lead Independent Director with defined authorities (agenda-setting coordination, presiding over executive sessions, shareholder outreach), which the Board asserts mitigates potential conflicts inherent in the CEO/Chair combination .

Say-on-Pay & Shareholder Feedback

YearSay-on-Pay approval (%)
2024 meeting result (for 2023 comp)90% support (votes cast)

Company Performance Snapshot (context for pay-for-performance)

Metric (FY2024)Value
GAAP Revenue ($B)4.03; +11% YoY
GAAP Operating Income ($M)600.0
Net Income ($M)576.2; +6% YoY
Operating Cash Flow ($M)989.5; +32% YoY
Non-GAAP Operating Margin (%)18.8%
5-year absolute TSR (to 12/31/24)42%
5-year TSR CAGR7%

Equity Plan Mechanics (select terms)

  • Change in control treatment under the equity incentive plan allows for continuation/assumption/substitution or acceleration if the successor refuses; aligns with CIC protections disclosed .
  • Director equity/compensation framework and ownership guidelines exist but are not applicable to Sayer as an employee director .

Risk Indicators and Red Flags (observed)

  • 2024 annual bonus: 0% payout due to unmet company objectives, indicating guardrails on discretion and pay-for-performance discipline .
  • 2024 PSUs: corporate metric below threshold; no vesting—suggests challenging targets and outcome-based equity .
  • Policies prohibit hedging/pledging and single-trigger acceleration; clawback in place—reducing governance risk .
  • Large unvested equity and sizable CIC protections (3x salary and target bonus; full acceleration) could influence executive retention and M&A dynamics .

Investment Implications

  • Pay-for-performance alignment: Zero 2024 bonus and no vesting of 2024 PSUs despite solid margin progress reflect rigorous targets and compensation discipline; equity remains the dominant pay lever (50/50 PSU/RSU for CEO), aligning with long-term TSR and revenue goals .
  • Retention vs. overhang: Significant outstanding RSUs/PSUs ($30.36M combined at 12/31/24) support retention but create periodic vesting supply; CEO is subject to a 12-month post-vesting hold, partially mitigating near-term selling pressure .
  • Governance balance: Combined CEO/Chair role is offset by a robust Lead Independent Director structure and majority-independent Board/committees; 90% Say-on-Pay support indicates broad shareholder acceptance of the program .
  • Downside/Upside asymmetry in CIC: Double-trigger benefits (3x salary and bonus; 100% equity acceleration) are competitive and could reduce perceived personal risk in strategic transactions; investors should factor potential dilution/expense in a change-of-control scenario .

Overall, Sayer’s long tenure, accounting/operational pedigree, and equity-heavy incentives tie realizable pay to growth and TSR. 2024 outcomes (bonus = 0; PSUs not earned) underscore a high bar, while sizable unvested equity and CIC protections bolster retention but can add overhang/transaction optics .